
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (06): 734-741.DOI: 10.12114/j.issn.1007-9572.2022.0630
Special Issue: 脑健康最新研究合辑
• Big Data Research • Previous Articles Next Articles
Received:2022-05-23
Revised:2022-09-30
Published:2023-02-20
Online:2022-10-13
Contact:
RANG Weiqing
About author:
通讯作者:
让蔚清
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0630
| 人群 | 年份(年) | APC(95%CI)(%) | Z值 | P值 | AAPC(95%CI)(%) | Z值 | P值 |
|---|---|---|---|---|---|---|---|
| 总人群 | 2000—2014 | -1.02(-1.08,-0.96) | -34.06 | <0.001 | -0.68(-0.76,-0.60) | -16.68 | <0.001 |
| 2014—2019 | 0.27(-0.01,0.55) | 2.03 | 0.060 | ||||
| 男性 | 2000—2004 | -0.16(-0.52,0.20) | -0.99 | 0.346 | -0.47(-0.66,0.29) | -5.11 | <0.001 |
| 2004—2007 | -1.33(-2.24,-0.24) | -2.74 | 0.023 | ||||
| 2007—2015 | -0.60(-0.74,-0.46) | -9.57 | <0.001 | ||||
| 2015—2019 | 0.11(-0.20,0.42) | 0.81 | 0.441 | ||||
| 女性 | 2000—2006 | -1.55(-1.73,-1.37) | -18.87 | <0.001 | -0.87(-0.96,-0.79) | -19.17 | <0.001 |
| 2006—2014 | -1.21(-1.35,-1.07) | -19.10 | <0.001 | ||||
| 2014—2019 | 0.49(0.27,0.71) | 4.88 | <0.001 |
Table 1 Trends of ASMR of brain cancers in the whole population,male and female populations in China from 2000 to 2019
| 人群 | 年份(年) | APC(95%CI)(%) | Z值 | P值 | AAPC(95%CI)(%) | Z值 | P值 |
|---|---|---|---|---|---|---|---|
| 总人群 | 2000—2014 | -1.02(-1.08,-0.96) | -34.06 | <0.001 | -0.68(-0.76,-0.60) | -16.68 | <0.001 |
| 2014—2019 | 0.27(-0.01,0.55) | 2.03 | 0.060 | ||||
| 男性 | 2000—2004 | -0.16(-0.52,0.20) | -0.99 | 0.346 | -0.47(-0.66,0.29) | -5.11 | <0.001 |
| 2004—2007 | -1.33(-2.24,-0.24) | -2.74 | 0.023 | ||||
| 2007—2015 | -0.60(-0.74,-0.46) | -9.57 | <0.001 | ||||
| 2015—2019 | 0.11(-0.20,0.42) | 0.81 | 0.441 | ||||
| 女性 | 2000—2006 | -1.55(-1.73,-1.37) | -18.87 | <0.001 | -0.87(-0.96,-0.79) | -19.17 | <0.001 |
| 2006—2014 | -1.21(-1.35,-1.07) | -19.10 | <0.001 | ||||
| 2014—2019 | 0.49(0.27,0.71) | 4.88 | <0.001 |
| 年份(年) | CMR (1/10万) | 累加序列 | 滑动平均序列 | 指数规律性检验(级比) | 光滑性检验(光滑比) |
|---|---|---|---|---|---|
| 2000 | 3.59 | 3.59 | — | — | — |
| 2001 | 3.62 | 7.20 | 5.39 | 2.01 | 1.01 |
| 2002 | 3.64 | 10.84 | 9.02 | 1.51 | 0.51 |
| 2003 | 3.64 | 14.48 | 12.66 | 1.34 | 0.34 |
| 2004 | 3.68 | 18.16 | 16.32 | 1.25 | 0.25 |
| 2005 | 3.69 | 21.85 | 20.00 | 1.20 | 0.20 |
| 2006 | 3.68 | 25.53 | 23.69 | 1.17 | 0.17 |
| 2007 | 3.70 | 29.24 | 27.38 | 1.15 | 0.15 |
| 2008 | 3.75 | 32.98 | 31.11 | 1.13 | 0.13 |
| 2009 | 3.79 | 36.78 | 34.88 | 1.12 | 0.12 |
| 2010 | 3.83 | 40.61 | 38.70 | 1.10 | 0.10 |
| 2011 | 3.85 | 44.46 | 42.54 | 1.09 | 0.09 |
| 2012 | 3.88 | 48.34 | 46.40 | 1.09 | 0.09 |
| 2013 | 3.91 | 52.25 | 50.30 | 1.08 | 0.08 |
| 2014 | 3.99 | 56.25 | 54.25 | 1.08 | 0.08 |
| 2015 | 4.05 | 60.30 | 58.27 | 1.07 | 0.07 |
| 2016 | 4.15 | 64.45 | 62.38 | 1.07 | 0.07 |
| 2017 | 4.24 | 68.69 | 66.57 | 1.07 | 0.07 |
| 2018 | 4.35 | 73.05 | 70.87 | 1.06 | 0.06 |
| 2019 | 4.47 | 77.51 | 75.28 | 1.06 | 0.06 |
Table 2 Sequence and feasibility test of crude mortality rate of brain cancers in China from 2000 to 2019
| 年份(年) | CMR (1/10万) | 累加序列 | 滑动平均序列 | 指数规律性检验(级比) | 光滑性检验(光滑比) |
|---|---|---|---|---|---|
| 2000 | 3.59 | 3.59 | — | — | — |
| 2001 | 3.62 | 7.20 | 5.39 | 2.01 | 1.01 |
| 2002 | 3.64 | 10.84 | 9.02 | 1.51 | 0.51 |
| 2003 | 3.64 | 14.48 | 12.66 | 1.34 | 0.34 |
| 2004 | 3.68 | 18.16 | 16.32 | 1.25 | 0.25 |
| 2005 | 3.69 | 21.85 | 20.00 | 1.20 | 0.20 |
| 2006 | 3.68 | 25.53 | 23.69 | 1.17 | 0.17 |
| 2007 | 3.70 | 29.24 | 27.38 | 1.15 | 0.15 |
| 2008 | 3.75 | 32.98 | 31.11 | 1.13 | 0.13 |
| 2009 | 3.79 | 36.78 | 34.88 | 1.12 | 0.12 |
| 2010 | 3.83 | 40.61 | 38.70 | 1.10 | 0.10 |
| 2011 | 3.85 | 44.46 | 42.54 | 1.09 | 0.09 |
| 2012 | 3.88 | 48.34 | 46.40 | 1.09 | 0.09 |
| 2013 | 3.91 | 52.25 | 50.30 | 1.08 | 0.08 |
| 2014 | 3.99 | 56.25 | 54.25 | 1.08 | 0.08 |
| 2015 | 4.05 | 60.30 | 58.27 | 1.07 | 0.07 |
| 2016 | 4.15 | 64.45 | 62.38 | 1.07 | 0.07 |
| 2017 | 4.24 | 68.69 | 66.57 | 1.07 | 0.07 |
| 2018 | 4.35 | 73.05 | 70.87 | 1.06 | 0.06 |
| 2019 | 4.47 | 77.51 | 75.28 | 1.06 | 0.06 |
| [1] |
赫捷,魏文强. 2019中国肿瘤登记年报[M]. 北京:人民卫生出版社,2019:193-197.
|
| [2] |
|
| [3] |
沈洪兵. 肿瘤分子流行病学[M]. 北京:人民卫生出版社,2014.
|
| [4] |
|
| [5] |
韩仁强,周金意,郑荣寿,等. 2014年中国脑瘤发病与死亡分析[J]. 中国肿瘤,2019,28(3):161-166. DOI:10.11735/j.issn.1004-0242.2019.03.A001.
|
| [6] |
韩仁强,周金意,张思维,等. 2015年中国脑瘤发病与死亡分析[J]. 中国肿瘤,2021,30(1):29-34. DOI:10.11735/j.issn.1004-0242.2021.01.A002.
|
| [7] | |
| [8] |
|
| [9] |
屈彦,王天一,杨津,等. GBD数据库的数据提取方法与流程[J]. 中国循证心血管医学杂志,2019,11(9):1043-1046. DOI:10.3969/j.issn.1674-4055.2019.09.04.
|
| [10] |
GBD Demographics Collaborators. Global age-sex-specific fertility,mortality,healthy life expectancy (HALE),and population estimates in 204 countries and territories,1950-2019:a comprehensive demographic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1160-1203. DOI:10.1016/S0140-6736(20)30977-6.
|
| [11] |
|
| [12] |
许忠宇. 2001~2015年深圳市肺癌发病的年龄-时期-队列模型分析[D]. 武汉:华中科技大学,2018.
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
邓聚龙. 灰色系统理论教程[M]. 武汉:华中理工大学出版社,1990.
|
| [17] |
张鹏,李颖男. GM(1,1)模型的优化与应用[J]. 太原师范学院学报(自然科学版),2021,20(4):14-19,54.
|
| [18] |
刘丽娜. 灰色GM(1,1)模型的优化及其应用[D]. 秦皇岛:燕山大学,2014.
|
| [19] |
何家赓,侯建忠,闫贻忠. 2005—2013年中国肿瘤登记地区女性乳腺癌死亡及疾病负担时间趋势分析[J]. 中华肿瘤防治杂志,2019,26(8):523-528. DOI:10.16073/j.cnki.cjcpt.2019.08.001.
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
国家卫生健康委老龄健康司. 2020年度国家老龄事业发展公报[EB/OL].(2021-10-15)[2022-07-02].
|
| [27] |
|
| [28] |
张云飞,刘培民. 中医药治疗脑瘤的研究进展[J]. 中医临床研究,2015,7(29):145-146.
|
| [29] |
|
| [30] |
GBD Brain and Other CNS Cancer Collaborators. Global,regional,and national burden of brain and other CNS cancer,1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol,2019,18(4):376-393. DOI:10.1016/S1474-4422(18)30468-X.
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
查震球,刘志荣,郑荣寿,等. 2008—2012年中国肿瘤登记地区脑及神经系统肿瘤发病与死亡分析[J]. 中华疾病控制杂志,2018,22(11):1101-1105. DOI:10.16462/j.cnki.zhjbkz.2018.11.003.
|
| [1] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [2] | ZHANG Zeyu, LI Chunhui. Ischemic Heart Disease Burden Attributable to Second-hand Smoke in China from 1990 to 2021 [J]. Chinese General Practice, 2026, 29(20): 2903-2912. |
| [3] | SUN Songpeng, XU Fangfang, LONG Junhong, WANG Zhanjun, CAO Qiaorong, WAN Weiping, LI Tianyu, LIN Mei, TIAN Ying, SHI Bin, WU Yao, WANG Jianguo, LI Xinjian, HUO Xingxiao, LIANG Longyu, CHU Hongchuan, ZHOU Yangyang, ZHANG Zhiyun, ZHANG Shuxin, JIA Shan. Construction and Clinical Value of the Hemorrhoids Severity and Surgical Risk Prediction Score [J]. Chinese General Practice, 2026, 29(20): 2879-2886. |
| [4] | WU Yixuan, XIAO Liangman, LIU Xin, YAN Ziqi, WANG Yuting, LIN Shumin, ZHUANG Lixing. Analysis of the Disease Burden of Parkinson's Disease in China and Globally from 1990 to 2021 and Prediction of Future Trends [J]. Chinese General Practice, 2026, 29(20): 2895-2902. |
| [5] | ZHAI Naisheng, HUANG Lihua, ZHANG Ye. Research on the Predictive Ability of Isokinetic Strength Testing for Knee Joint Extension of 1-repetition Maximum [J]. Chinese General Practice, 2026, 29(17): 2382-2386. |
| [6] | LIU Fan, CHEN Qiuyu, LI Jing. Development and Validation of a Nighttime Hypertension Screening Model for Subclinical High-risk Populations: a Single-center Cohort Study [J]. Chinese General Practice, 2026, 29(15): 1998-2005. |
| [7] | LI Zhen, WANG Chengyong. Association of Neutrophil-to-lymphocyte Ratio, Systemic Immune-inflammation Index, and Monocyte-to-lymphocyte Ratio with Disease Prognosis in Patients with Advanced Prostate Cancer [J]. Chinese General Practice, 2026, 29(14): 1878-1882. |
| [8] | WANG Siman, ZHANG Mengchu, LI Wen, XU Ai, XU Jin, GUO Rui, YAN Haixia. Research on the Construction of a Risk Prediction Model for Primary Hypertension with Left Ventricular Hypertrophy Based on TCM Syndromes and Pulse Graph Parameters [J]. Chinese General Practice, 2026, 29(14): 1840-1848. |
| [9] | HU Jiaqi, LI Duan, FANG Hao, FAN Xingying, DU Wei, ZHOU Hanni. Study on Predictive Model of Non-genetic Risk Factors for Hyperuricemia in a Physical Examination Cohort [J]. Chinese General Practice, 2026, 29(10): 1324-1333. |
| [10] | YU Xinyan, MA Zhong, CAO Fan, SU Peng, LIN Ying, ZHANG Haicheng. Predicting the Risk of Depression in Elderly Patients with Cardiovascular Metabolic Diseases Using Single-lead Wearable Electrocardiography at the Community Level [J]. Chinese General Practice, 2026, 29(10): 1300-1310. |
| [11] | ZHANG Ziyu, HAN Shukui, MA Xin, SONG Panpan, MA Jinxiang, REN Yitao, CHEN Hongru. The Disease Burden of Drug Use Disorders in the Chinese Population from 1990 to 2021 and Trend Predictions from 2022 to 2046 [J]. Chinese General Practice, 2026, 29(08): 1069-1076. |
| [12] | WANG Xiaonan, RUAN Xiaonan, LIU Yang, WU Kang, QIU Hua, LIU Qingping, SONG Jiahui, GAO Jiaojiao, ZHOU Yi, LIU Xiaolin. Correlation between Anthropometric Indices and the Risk of Stroke: a Nested Case-control Study [J]. Chinese General Practice, 2026, 29(08): 1020-1028. |
| [13] | LI Liqing, LIU Wenhui, YANG Jiayi, WANG Fang. Spatio-temporal Evolution and Trend Prediction of Coupled and Coordinated Development of Quality Medical Resources and Economy and Society in Six Central Provinces of China [J]. Chinese General Practice, 2026, 29(07): 844-850. |
| [14] | LIU Fan, LI Jiali, KE Lixin, ZHANG Qiang, CHEN Jiahui, LU Cuncun, ZHAO Xinke. Disease Burden of Hypercholesterolemia among Individuals Aged 60 and above Globally and in China from 1990 to 2021: Trend Analysis and Model-based Projection [J]. Chinese General Practice, 2026, 29(05): 631-640. |
| [15] | JIANG Xiaorui, YAN Yuyao, WEI Jingjing, QIAO Lijie, PENG Guangcao, ZHU Mingjun. Systematic Review of Risk Prediction Models for Concurrent Heart Failure with Coronary Heart Disease [J]. Chinese General Practice, 2026, 29(03): 393-402. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||